HER2-mutant NSCLC

2 · 20 / page

Ask MedXY AI

Latest news

Tag

newsHER2-mutant NSCLConcology

Emerging Promise of Sevabertinib for HER2-Mutant Non-Small-Cell Lung Cancer: A New Hope

By MedXY|Oct 25, 2025

This article reviews recent clinical trial data showing sevabertinib’s efficacy and safety in treating HER2-mutant NSCLC, highlighting its potential to fill an unmet therapeutic gap.

newsclinical trialHER2-mutant NSCLC

HER2-mutant NSCLC

Latest news

Emerging Promise of Sevabertinib for HER2-Mutant Non-Small-Cell Lung Cancer: A New Hope

Zongertinib: A Promising Oral Targeted Therapy for Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer